RxDoctor Payments Data

Paul Schmidt, MD

Neurology · Ormond Beach, FLNPI 1245252444

Payments from drug & device makers

$8,998in general payments, 2019–2025

Across 449 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$891
  • Novartis$590
  • UCB, Inc.$506
  • Takeda Pharmaceuticals U.S.A., Inc.$466
  • Protega Pharmaceutials Inc$291
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$8,93599%
  • Education$631%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)109$2,213
Pfizer59$891
Novartis31$590
UCB, Inc.20$506
Takeda Pharmaceuticals U.S.A., Inc.19$466
Protega Pharmaceutials Inc5$291
EMD Serono, Inc.11$259
Biogen12$239
Scilex Pharmaceuticals Inc.14$227
Otsuka America Pharmaceutical, Inc.9$184
Lilly USA, LLC10$179
Sanofi9$173
Eisai Inc.7$169
Harmony Biosciences LLC4$157
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$142
Argenx US, Inc.6$138
Collegium Pharmaceutical, Inc.8$137
Tanabe Pharma America, Inc.6$133
Teva Pharmaceuticals USA, Inc.7$125
Johnson & Johnson(2 entities)5$96
Neurelis, Inc.6$95
Acadia Pharmaceuticals Inc4$87
Catalyst Pharmaceuticals, Inc.3$84
Lundbeck LLC5$83
Neurocrine Biosciences, Inc.4$79
Amneal Pharmaceuticals LLC4$76
AstraZeneca3$74
Jazz Pharmaceuticals Inc.3$67
Impel Pharmaceuticals Inc.3$61
SK Life Science, Inc.3$60
Mallinckrodt Hospital Products Inc.3$59
Bristol Myers Squibb3$51
Supernus Pharmaceuticals, Inc.3$47
Biohaven Pharmaceuticals, Inc.3$47
Biohaven Pharmaceutical Holding Company Ltd.2$46
MDD US Operations, LLC3$46
Avanir Pharmaceuticals, Inc.2$44
Virtus Pharmaceuticals LLC3$41
Sunovion Pharmaceuticals Inc.2$36
Greenwich Biosciences, Inc.2$35
Amgen2$35
C2n Diagnostics, LLC1$34
Livanova USA, Inc.2$32
Genentech USA, Inc.2$31
Boston Scientific2$29
CSL Behring1$29
Idorsia Pharmaceuticals US Inc2$28
Vertex1$26
GE HealthCare1$26
TG Therapeutics, Inc.1$23
Upsher-smith Laboratories LLC1$19
Acorda Therapeutics, Inc1$19
Sandoz1$18
Nevro Corp.1$18
Merz Pharmaceuticals, LLC1$17
Grifols USA, LLC1$16
Merck1$15
Boehringer Ingelheim1$14
Masimo Corporation1$13
Avion Pharmaceuticals1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,998 in reported general payments places this provider in the 60th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida

Medicare billing

Part B allowed, 2024
$78,740
Medicare patients
217
Services billed
611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin29$726
Gabapentin41$663
Levetiracetam28$617
Memantine Hcl ErMemantine Hcl22$557
Donepezil Hcl53$492
Duloxetine Hcl14$464
Primidone20$308
Carbidopa-LevodopaCarbidopa/Levodopa21$307
Nortriptyline Hcl12$124
Propranolol Hcl21$91

Paid to pharmacies, not to this prescriber.

Other neurology in Ormond Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →